Stay updated on Lebrikizumab Long-term Safety Efficacy AD Clinical Trial

Sign up to get notified when there's something new on the Lebrikizumab Long-term Safety Efficacy AD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lebrikizumab Long-term Safety Efficacy AD Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.1 to v3.3.2; no impact on the study details or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-30T07:52:51.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Publication notes now state that PubMed feeds are automatically filled and add Revision: v3.3.1; the previous PubMed-based description has been removed (Revision: v3.2.0).
    Difference
    0.4%
    Check dated 2025-11-23T08:11:13.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Added a new Lebrikizumab long-term data publication to the Publications section and removed the NIH funding-status notice.
    Difference
    0.1%
    Check dated 2025-11-16T06:04:08.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page adds Open-Label Extension Addendum arms for Lebrikizumab Q4W and Q8W (up to 32 weeks) and new primary/secondary outcomes (AE discontinuation, IGA 0/1 at Week 100, EASI-75 at Week 100), plus updated study protocol documents.
    Difference
    0.4%
    Check dated 2025-11-09T03:27:38.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    There are no significant changes detected on the page; the study details and layout appear unchanged from the previous view.
    Difference
    0.1%
    Check dated 2025-11-02T00:17:44.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    Major change: update to v3.2.0 with a prominent notice about government funding status and operating status; removal of v3.1.0. If any time-sensitive content is shown elsewhere, it may now reflect the new version and funding status.
    Difference
    1%
    Check dated 2025-10-04T04:10:21.000Z thumbnail image

Stay in the know with updates to Lebrikizumab Long-term Safety Efficacy AD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lebrikizumab Long-term Safety Efficacy AD Clinical Trial page.